武田薬品工業【JP:4502】損益計算書
時価総額
¥8.08兆
PER
52.3倍
消化器系疾患、希少疾患、血漿分画製剤、オンコロジー、ワクチン、ニューロサイエンスの研究開発と製造販売を行う医薬品事業。
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| 売上高 | 1,508,932 | 1,557,267 | 1,691,930 | 1,777,824 | 1,807,378 | 1,732,051 | 1,770,531 | 2,097,224 | 3,291,188 | 3,197,812 | 3,569,006 | 4,027,478 | 4,263,762 | 4,581,551 |
| 売上原価 | - | - | - | 290,992 | 327,037 | 349,809 | 290,952 | 659,690 | 1,089,764 | 994,308 | 1,106,846 | 1,244,072 | 1,426,678 | 1,580,217 |
| 売上総利益 | - | - | - | 485,230 | 449,961 | 387,994 | 368,510 | 365,666 | 373,188 | 390,967 | 556,719 | 417,164 | 350,070 | 321,456 |
| 売上総利益率（％） | - | - | - | |||||||||||
| 営業利益 | - | - | - | 110,066 | 94,232 | 70,262 | 67,736 | 204,969 | 100,408 | 509,269 | 460,844 | 490,505 | 214,075 | 342,586 |
| 営業費用 | - | - | - | 375,164 | 355,729 | 317,732 | 300,774 | 717,599 | 964,737 | 875,663 | 886,361 | 997,309 | 1,053,819 | 1,104,766 |
| 経常（税引前）利益 | 270,330 | 133,068 | 158,851 | -145,437 | 120,539 | 143,346 | 217,205 | 94,896 | -60,754 | 366,235 | 302,571 | 375,090 | 52,791 | 175,084 |
| 法人税等合計 | - | - | - | 68,717 | 26,092 | 20,165 | 65,574 | -14,118 | -105,044 | -9,936 | 72,405 | 58,052 | -91,406 | 66,941 |
| 純利益 | 372,523 | 148,583 | 106,658 | -145,775 | 80,166 | 114,940 | 186,886 | 109,126 | 44,241 | 376,005 | 230,059 | 317,017 | 144,067 | 107,928 |
| 一株あたり利益 | 157.29 | 188.21 | 135.1 | -185.37 | 102.26 | 147.15 | 239.35 | 113.5 | 28.41 | 240.72 | 147.14 | 204.29 | 92.09 | 68.36 |
| 希薄化後一株あたり利益 | 157.26 | 166.21 | 114.32 | 77.1 | 334.88 | 138.6 | 239.18 | 112.86 | 28.25 | 238.96 | 145.87 | 201.94 | 91.16 | 67.23 |
| 配当性向（%） | - | - | - | - | - | - | - | - | ||||||
| 一株あたり配当金 | 180 | 180 | 180 | 180 | 180 | 180 | 180 | 180 | 180 | 180 | 180 | 180 | 188 | 196 |